Tako-Tsubo Cardiomyopathy and Cardiac Syndrome X: New Insights Into the Pathophysiology (ENDAUT)

April 25, 2016 updated by: Professor Augusto Gallino, Ospedale San Giovanni Bellinzona

Tako-Tsubo Cardiomyopathy and Cardiac Syndrome X: New Insights Into the Pathophysiology of Two Orphan Cardiac Diseases

Tako-Tsubo Cardiomyopathy (TTC) and Cardiac Syndrome X (CSX) are respectively acute and chronic cardiac conditions whose clinical presentation, mimicking the onset of acute myocardial ischemia in absence of epicardial coronary disease, has progressively gained the interest of the scientific community. However, despite significant progress, their underlying pathophysiology, which seems to evoke some similarities, still remains elusive. Endothelial dysfunction and autonomic imbalance have both been individually implied in their puzzling pathogenesis.

The investigators plan to conduct our study in a cohort of TTC patients, CSX patients and healthy volunteers with the following primary objective: to assess the response of endothelial function (through the Endopat score) to the autonomic tone activation induced by a 10-minute stress mental test. The assessment of autonomic tone during activation through the evaluation of Spontaneous BaRoreflex Sensitivity (BRS) and its correlation with endothelial function (Endopat score) will represent secondary objectives.

Our study will enroll 15 patients with TTC at least six months after the event, 15 patients with classic CSX and 15 healthy volunteers who will serve as control.

Study Overview

Study Type

Interventional

Enrollment (Actual)

39

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Canton Ticino
      • Bellinzona, Canton Ticino, Switzerland, 6500
        • Ospedale Regionale di Bellinzona e Valli - Ospedale San Giovanni, Bellinzona

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with the Mayo Clinic's criteria established diagnosis of TTC at least 6 month after the acute event
  • Patients with CSX defined by the presence of anginal pain, positive exercise stress testing and negative coronary angiography.
  • A comparable cohort of healthy volunteers age and sex-matched with patients

Exclusion Criteria:

  • Short-term life-threatening pathology (life expectancy < 6 months)
  • Physically unable to participate in the study
  • Compliance not guaranteed
  • Pregnancy
  • Conditions that make BRS and Endopat measurements impossible

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Coronary X syndrome
BaroReflex Sensitivity, endothelial function measurement
no other
Other Names:
  • BaroReflex Sensitivity measurement by volume-clamp method (Finapress)
  • Endothelial function measured by Endopat
Other: Tako-tsubo cardiomyopathy
BaroReflex Sensitivity, endothelial function measurement
no other
Other Names:
  • BaroReflex Sensitivity measurement by volume-clamp method (Finapress)
  • Endothelial function measured by Endopat
Other: Healty Volunteers
BaroReflex Sensitivity, endothelial function measurement
no other
Other Names:
  • BaroReflex Sensitivity measurement by volume-clamp method (Finapress)
  • Endothelial function measured by Endopat

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in endothelial function in response to autonomic tone (Endopat score)
Time Frame: Baseline
Difference in endothelial function assessed by Endopat score in response to autonomic tone induced by 10-minute mental stress test between the three groups (CSX, TTC, healty volunteers)
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BaroReflex Sensitivity (Sensitivity measurement by volume-clamp method (Finapress)
Time Frame: Baseline
Changes in BaroReflex Sensitivity from baseline in three three groups (CSX, TTC, healty volunteers)
Baseline
BaroReflex Sensitivity and endothelial dysfunction (
Time Frame: Baseline
Correlation with between BaroReflex Sensitivity [volume clamp method] and EndoPAT score in the three groups (CSX, TTC, healty volunteers)
Baseline
Endothelial dysfunction (Changes in Endopat score)
Time Frame: Baseline
Changes in Endopat score from baseline in three three groups (CSX, TTC, healty volunteers)
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Augusto Gallino, Prof MD, Ospedale Regionale di Bellinzona e Valli - Ospedale San Giovanni, Bellinzona
  • Study Chair: Mattia Cattaneo, MD, Ospedale Regionale di Bellinzona e Valli - Ospedale San Giovanni, Bellinzona
  • Study Chair: Alessandra Pia Porretta, MD, Ospedale Regionale di Bellinzona e Valli - Ospedale San Giovanni, Bellinzona

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2013

Primary Completion (Actual)

April 1, 2016

Study Completion (Actual)

April 1, 2016

Study Registration Dates

First Submitted

November 26, 2014

First Submitted That Met QC Criteria

December 3, 2014

First Posted (Estimate)

December 4, 2014

Study Record Updates

Last Update Posted (Estimate)

April 26, 2016

Last Update Submitted That Met QC Criteria

April 25, 2016

Last Verified

April 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Takotsubo Cardiomyopathy

Clinical Trials on BaroReflex Sensitivity, endothelial function measurement

Subscribe